2022年 · 第102卷第20期

High-grade endometrial stromal sarcoma (HG-ESS) is a histological subtype of endometrial stromal sarcoma (EST). The treatment principle is mainly surgery, supplemented by endocrine therapy, radiotherapy and chemotherapy, and the overall prognosis is poor. The effect is uncertain, and new treatment strategies such as immunotherapy have become the hot topic of current research. The latest research shows that HG-ESS can benefit from immunotherapy.

real-time continuous glucose monitoring (rtCGM) has become a key component of intensive insulin regimen treatment and is considered the standard of care for patients with type 1 diabetes (T1DM). There have been few long-term studies to evaluate the efficacy of rtCGM and various insulin injection methods in the past. The research group previously reported the results of the COMISAIR study, which is a 1-year, non-randomized, real-world study that evaluates the long-term use of sensor-augmented insulin regimens (SAIR). In the current 3-year follow-up study, investigators investigated the effects of SAIR interventions on glycemic control and treatment persistence in a larger cohort, aiming to provide further supporting evidence for the use of rtCGM in the management of T1DM.